These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32154984)

  • 21. Multiplicity of morphologies in poly (l-lactide) bioresorbable vascular scaffolds.
    Ailianou A; Ramachandran K; Kossuth MB; Oberhauser JP; Kornfield JA
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11670-11675. PubMed ID: 27671659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of three-dimensionally printed vascular stents of bioresorbable poly(l-lactide-co-caprolactone).
    Zhao J; Song G; Zhao Q; Feng H; Wang Y; Anderson JM; Zhao H; Liu Q
    J Biomed Mater Res B Appl Biomater; 2023 Mar; 111(3):656-664. PubMed ID: 36420745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative reliability and performance study of different stent designs in terms of mechanical properties: foreshortening, recoil, radial force, and flexibility.
    Kim DB; Choi H; Joo SM; Kim HK; Shin JH; Hwang MH; Choi J; Kim DG; Lee KH; Lim CH; Yoo SK; Lee HM; Sun K
    Artif Organs; 2013 Apr; 37(4):368-79. PubMed ID: 23461583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of acute recoil between bioabsorbable poly-L-lactic acid XINSORB stent and metallic stent in porcine model.
    Wu Y; Shen L; Wang Q; Ge L; Xie J; Hu X; Sun A; Qian J; Ge J
    J Biomed Biotechnol; 2012; 2012():413956. PubMed ID: 23093843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design optimization of stent and its dilatation balloon using kriging surrogate model.
    Li H; Liu T; Wang M; Zhao D; Qiao A; Wang X; Gu J; Li Z; Zhu B
    Biomed Eng Online; 2017 Jan; 16(1):13. PubMed ID: 28086895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late stent recoil of the bioabsorbable everolimus-eluting coronary stent and its relationship with plaque morphology.
    Tanimoto S; Bruining N; van Domburg RT; Rotger D; Radeva P; Ligthart JM; Serruys PW
    J Am Coll Cardiol; 2008 Nov; 52(20):1616-20. PubMed ID: 18992650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanical behavior of coronary stents investigated through the finite element method.
    Migliavacca F; Petrini L; Colombo M; Auricchio F; Pietrabissa R
    J Biomech; 2002 Jun; 35(6):803-11. PubMed ID: 12021000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel biodegradable drug-eluting stent composed of poly-L-lactic acid and amorphous calcium phosphate nanoparticles demonstrates improved structural and functional performance for coronary artery disease.
    Lan Z; Lyu Y; Xiao J; Zheng X; He S; Feng G; Zhang Y; Wang S; Kislauskis E; Chen J; McCarthy S; Laham R; Jiang X; Wu T
    J Biomed Nanotechnol; 2014 Jul; 10(7):1194-204. PubMed ID: 24804540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation and constitutive modelling of biaxially stretched poly(L-lactic acid) sheet for application in coronary stents.
    Blair RW; Dunne NJ; Lennon AB; Menary GH
    J Mech Behav Biomed Mater; 2019 Sep; 97():346-354. PubMed ID: 31153116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of parameters on mechanical properties of poly (L-lactic acid) helical stents.
    Zhao G; Liu J; Liu M; Tian Y; Cheng J; Liu W; Ni Z
    J Biomed Mater Res B Appl Biomater; 2022 Jul; 110(7):1705-1712. PubMed ID: 35157351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly (l-lactic acid) bioresorbable scaffolds versus metallic drug-eluting stents for the treatment of coronary artery disease: A meta-analysis of 11 randomized trials.
    Verdoia M; Kedhi E; Suryapranata H; Galasso G; Dudek D; De Luca G
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):813-824. PubMed ID: 31730255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-objective optimization of coronary stent using Kriging surrogate model.
    Li H; Gu J; Wang M; Zhao D; Li Z; Qiao A; Zhu B
    Biomed Eng Online; 2016 Dec; 15(Suppl 2):148. PubMed ID: 28155700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiopaque Fully Degradable Nanocomposites for Coronary Stents.
    Ang HY; Toong D; Chow WS; Seisilya W; Wu W; Wong P; Venkatraman SS; Foin N; Huang Y
    Sci Rep; 2018 Nov; 8(1):17409. PubMed ID: 30479353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A biodegradable stent based on poly(L-lactide) and poly(4-hydroxybutyrate) for peripheral vascular application: preliminary experience in the pig.
    Bünger CM; Grabow N; Sternberg K; Goosmann M; Schmitz KP; Kreutzer HJ; Ince H; Kische S; Nienaber CA; Martin DP; Williams SF; Klar E; Schareck W
    J Endovasc Ther; 2007 Oct; 14(5):725-33. PubMed ID: 17924740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of
    Milosevic M; Anic M; Nikolic D; Geroski V; Milicevic B; Kojic M; Filipovic N
    Front Med Technol; 2021; 3():724062. PubMed ID: 35047953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study on the deformation behavior and mechanical properties of new lower extremity arterial stents.
    Feng H; Shi X; Wang T; Wang K; Su J
    Comput Methods Programs Biomed; 2024 Apr; 247():108094. PubMed ID: 38401508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crimping-induced structural gradients explain the lasting strength of poly l-lactide bioresorbable vascular scaffolds during hydrolysis.
    Ramachandran K; Di Luccio T; Ailianou A; Kossuth MB; Oberhauser JP; Kornfield JA
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10239-10244. PubMed ID: 30224483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
    Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
    JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents.
    Gomez-Lara J; Garcia-Garcia HM; Onuma Y; Garg S; Regar E; De Bruyne B; Windecker S; McClean D; Thuesen L; Dudek D; Koolen J; Whitbourn R; Smits PC; Chevalier B; Dorange C; Veldhof S; Morel MA; de Vries T; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1190-8. PubMed ID: 21087756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three to four years outcomes of the absorb bioresorbable vascular scaffold versus second-generation drug-eluting stent: A meta-analysis.
    Goel S; Pasam RT; Chava S; Sharma A; Malik BA; Ayzenberg S; Frankel R; Shani J; Gidwani U
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):216-223. PubMed ID: 31002216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.